Nortrilen

Quick links to important sections

Nortrilen

Method of action: Antidepressant, Psychoanaleptics

Treatment option: Depression

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nortrilen

Property Description
Active ingredient Nortriptyline Hydrochloride
Form Capsule, Tablet, Oral Solution
Pharmacological class Tricyclic Antidepressant (TCA)
General purpose Mood stabilization and pain signal modulation
Origin Synthetic, Metabolite of Amitriptyline

What Type of Medicine is Nortrilen?

Nortrilen is a brand name for the prescription-only medication whose active substance is Nortriptyline Hydrochloride, formally classified as a Tricyclic Antidepressant (TCA). This medication belongs to the secondary amine sub-class of TCAs, distinguishing its pharmacological profile within the group of psychoactive agents. Nortriptyline is structurally differentiated from its tertiary amine precursor, Amitriptyline, as it is an active metabolite of Amitriptyline, meaning it is the beneficial compound formed in the body after the initial breakdown of that related drug.

Composition, Origin, and Available Forms

Nortriptyline Hydrochloride is a synthetic compound manufactured as a single-ingredient product, typically by companies such as Lundbeck or various generic distributors. It is presented as an oral preparation, commonly available in three distinct dosage forms: the standard capsule, tablet, and an oral solution. The oral route of administration makes it a practical option for long-term management. These forms are established oral preparations.

What is the General Purpose of Nortriptyline?

The general purpose of Nortriptyline is to help restore chemical balance in the central nervous system, an action clinically recognized for its influence on conditions where neurotransmitter imbalances are implicated. It achieves this by acting as a Norepinephrine Reuptake Inhibitor, which prevents nerve cells from prematurely clearing norepinephrine from the synaptic space. This pharmacological action is utilized to help achieve a stabilized emotional state and to provide effective modulation of the body’s perception of chronic pain signals, fulfilling the overall therapeutic intent of this specific TCA compound.

Regulatory References

  1. NIH: Nortriptyline for Pain

What side effects are possible with Nortrilen?

Possible side effects and safety information

The official safety profile for Nortrilen (Nortriptyline Hydrochloride) is structured by regulatory documents, classifying potential outcomes by frequency and affected body systems.

Adverse reactions are organized into System-Organ Classes, including Nervous System Disorders, Gastrointestinal Disorders, Cardiac Disorders, and Vascular Disorders. Many common effects reflect the drug's known anticholinergic activity and central sedation.

Frequency Classification Examples (Adverse Reaction)
Very Common Dry mouth, Sedation/Drowsiness, Headache
Common Constipation, Dizziness, Tremor, Blurred vision, Tachycardia, Orthostatic hypotension

Serious adverse reactions are explicitly documented in regulatory labeling. A mandated Boxed Warning is included concerning the increased risk of Suicidal Ideation and Behavior in children, adolescents, and young adults, particularly at the initiation of therapy or following dose changes. Other documented serious risks include potential for severe Cardiac Conduction Abnormalities (e.g., QTc prolongation and arrhythmias) and a lowered Seizure threshold.

Specific Population-Specific Safety Constraints exist. Older adults are noted to have heightened sensitivity, increasing the frequency of confusion, orthostatic hypotension, and falls. Furthermore, the concurrent use of Nortriptyline with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated due to the severe risk of Serotonin Syndrome. Safety documentation also restricts its use in individuals who have recently experienced a myocardial infarction.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Nortrilen (Nortriptyline) is classified in regulatory documents as a severe event with the potential for life-threatening outcomes. The profile of toxicity is defined by manifestations in two primary systems:

System Documented Manifestations
Cardiovascular Severe arrhythmias, hypotension, and a diagnostic QRS complex widening (ge 0.10 seconds) on ECG are documented risks, potentially leading to cardiac arrest and fatalities.
Central Nervous Symptoms range from agitation, seizures (convulsions), and delirium to profound CNS depression and coma. Anticholinergic effects like sinus tachycardia and urine retention may also be present.

Immediate Action Mandated by Regulators

Due to the risk of rapid deterioration and potentially fatal cardiac toxicity, government regulatory documents explicitly state that emergency medical attention must be sought immediately upon any suspicion of overdose. Hospital monitoring is required as soon as possible.

Management procedures are defined as symptomatic and supportive, requiring immediate and continuous ECG monitoring for at least six hours. The official labeling confirms that no specific antidote is known. Specialized consultation is recommended for complex management, and children are noted to be particularly sensitive to cardiotoxic effects.

Therapeutic Uses of Nortrilen

Nortrilen (Nortriptyline) is primarily applied across distinct clinical domains to provide targeted symptomatic relief and contribute to easing the overall symptom load associated with persistent conditions. The medication is used to address multiple symptomatic manifestations. Key therapeutic applications include supporting symptom management in cases of Major Depressive Disorder, addressing chronic nerve pain such as diabetic neuropathy or Postherpetic Neuralgia, and is applied in addressing the management of recurrent migraines.


Quick Fact: Relief for Chronic Pain

The medication is relevant in clinical settings marked by symptoms related to physical discomfort caused by long-term nerve damage. It is applied when additional management of discomfort is required, which may assist with maintaining functional stability.


The supportive relief assists with maintaining functional stability when symptoms are more noticeable, helping patients cope more steadily during difficult episodes. It supports patients by easing symptom clusters that appear as characteristic burning, stabbing, or shooting pain, or by contributing to a more stable emotional state.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The regulatory profile for Nortrilen (Nortriptyline) defines strict population-based rules for use.

Absolute Contraindications

Use is strictly prohibited for patients with known hypersensitivity to Nortriptyline or related compounds. It is also contraindicated for individuals who are taking or have taken a Monoamine Oxidase Inhibitor (MAOI) within the preceding 14 days. Furthermore, the medicine must not be used during the acute recovery period immediately following a Myocardial Infarction (heart attack).


Conditional Use and Age Limits

The medicine is primarily indicated for the adult population. Use in children and adolescents under 18 years is not recommended, as official regulatory documentation states that safety and effectiveness have not been established in this pediatric group. Use in older adults is permitted but requires caution. Restricted use applies to patients with specific comorbidities, including cardiovascular disorders, angle-closure glaucoma, a history of urinary retention, or severe hepatic impairment. For pregnancy and lactation, safe use has not been established, and official labeling requires the potential benefits to be carefully weighed against possible hazards.

What should I know about interactions with other medicines?

Nortrilen (nortriptyline) can interact with many other medications, increasing the risk of serious side effects. It is crucial to inform your healthcare provider about all prescription, over-the-counter drugs, and herbal supplements you are taking.

Major Contraindications

Nortrilen must never be used concurrently with Monoamine Oxidase Inhibitors (MAOIs), such as isocarboxazid, phenelzine, or tranylcypromine, or with linezolid or intravenous methylene blue. This combination can lead to a potentially fatal condition called Serotonin Syndrome, which includes symptoms like high blood pressure, confusion, and high body temperature. A washout period of at least 14 days is required when switching between Nortrilen and an MAOI.

Increased Risk of Serotonin Syndrome

Caution is needed when taking Nortrilen with other medications that increase serotonin, including Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine or sertraline, Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), other Tricyclic Antidepressants (TCAs), triptans, or the herbal supplement St. John's Wort.

Other Significant Interactions

Interacting Substance Potential Effect
CNS Depressants (e.g., alcohol, opioids, sedatives, antihistamines) Increases sedation and impairment; avoid concurrent use.
Cimetidine (for stomach ulcers) Can increase Nortrilen levels in the body, raising the risk of side effects.
CYP2D6 Inhibitors (e.g., quinidine, some SSRIs) May increase Nortrilen concentration, requiring dose adjustment.

It is essential to avoid alcohol as it can worsen the sedative effects of Nortrilen and impair judgment and coordination.

Mechanism of Action

Selective Inhibition of the Norepinephrine Transporter

Nortrilen (Nortriptyline) acts via several distinct pharmacological mechanisms, primarily involving key monoamine transporters and secondary receptor systems. Its primary mechanism involves acting as an inhibitor of the Norepinephrine Transporter ( NET), the protein responsible for clearing the neurotransmitter norepinephrine ( NE) from the synaptic cleft. By blocking the NET, the drug rapidly increases NE availability. The full adjustment of monoaminergic system function, however, requires chronic exposure leading to secondary neuroadaptive changes that take several weeks to complete.

Amplification of Descending Pain Signals

The elevated levels of norepinephrine and, to a lesser extent, serotonin, amplify the body's descending inhibitory pain pathway. This mechanism strengthens the natural signal transmission from the brainstem to the spinal cord, leading to an inhibition of nociceptive signal transmission in the dorsal horn of the spinal cord.

Collateral Blockade of Autonomic Receptors

Beyond its primary function, Nortriptyline also acts as an antagonist (blocker) at off-target receptors, notably Histamine H1 and Muscarinic Cholinergic ( mACh) receptors. This simultaneous, collateral activity can lead to depression of central vigilance and modulate various functions related to the autonomic nervous system (e.g., smooth muscle effects).

Dosage and Administration Information

Official Administration Guidelines

Nortrilen is strictly for oral administration and is available in forms including capsules, tablets, and oral solution. The medication can be taken with or without food, and preparation for the oral solution requires accurate measurement using a marked measuring device.

The administration protocol mandates a process of low-dose titration. For adults, the daily intake begins at a low level and is gradually increased toward a maintenance range of 75 mg to 100 mg per day. The dose must not exceed the maximum recommended daily limit of 150 mg.

Dosing is flexible: the total daily amount may be administered either in divided doses throughout the day or consolidated into a single, once-daily dose, often taken at night. For doses exceeding 100 mg daily, therapeutic drug monitoring is required to maintain plasma levels within the established optimal range of 50 to 150 ng/mL.

Usage instructions are modified for specific groups. Lower dosages, typically 30 mg to 50 mg per day, are recommended for older adults. Furthermore, the medicine is not recommended for use in patients under 18 years of age due to a lack of established safety and efficacy data. Treatment is considered a long-term course, and when discontinuation is necessary, the medication must be gradually withdrawn over several weeks.

Recent Clinical Evidence

Nortrilen: Recent Clinical Evidence

Research has explored Nortrilen in Major Depressive Disorder (MDD) through short-term Randomized Controlled Trials (RCTs) and systematic reviews. Research has examined the use of Nortrilen in conditions characterized by fluctuating manifestations. Trials typically included adults, with some studies involving older adults or patients difficult to treat with prior medications. These studies monitored outcomes by using standardized scales to measure changes in symptom severity. The evidence provides context regarding symptom patterns during the acute observation phase.


Evidence for Chronic Neuropathic Pain

Nortrilen was studied in research contexts involving conditions related to physical discomfort caused by long-term nerve issues, specifically Diabetic Peripheral Neuropathy (DPN) and Postherpetic Neuralgia (PHN). The research base includes short-duration randomized trials. Researchers examined patient-reported outcomes describing perceived discomfort, including measurements of pain intensity and interference with daily functioning. The evidence quality varies across studies; many trials have sample sizes that were modest, and the overall certainty remains low for some pain categories.


Evidence for Migraine Prophylaxis

Nortrilen was evaluated in research exploring conditions characterized by fluctuating or episodic manifestations, specifically for the prevention of recurrent migraines. Studies explored how symptoms changed over time by monitoring outcomes such as the number of headache attacks per month and the overall intensity. This research forms part of the broader evidence landscape regarding this class of medication in the context of migraine prophylaxis, but comparative evidence is lacking for dedicated Nortrilen studies against many modern preventative treatments.


Understanding Evidence Gaps and Uncertainty

Much of the core research is derived from studies with short observation periods, typically 6 to 12 weeks. This means that long-term effects are not well characterized based on the primary clinical trials, and limited information exists for populations such as children and adolescents. The research provides context regarding what is known—and what is still uncertain—about Nortrilen's profile in different contexts.

Key Studies & References

  1. Nortriptyline (Oral Route) Drug Information
  2. Nortriptyline for Pain (StatPearls - NIH National Library of Medicine)

Frequently Asked Questions (FAQ)

Common questions about Nortrilen (FAQ)


Q: Is Nortrilen the same drug as Pamelor, or are they different?

Nortrilen is a brand name for the prescription medicine whose active ingredient is nortriptyline hydrochloride. Official drug information confirms that Pamelor is also a brand name used for the exact same active ingredient, nortriptyline.


Q: What are the general differences between Nortrilen and related medications like Amitriptyline?

Nortriptyline is technically the active compound (a metabolite) formed when the body processes amitriptyline. Because it is a secondary amine, nortriptyline is generally described in authoritative clinical documents as being associated with a differentiated profile of sedating and anticholinergic effects compared to the parent drug, amitriptyline.


Q: What is the general difference between the dose used for depression and the dose used for pain relief?

Official information indicates that the starting and target dose ranges can differ depending on the prescribed condition. Dosage for pain management often starts at a lower level and is part of a specific titration process defined by the prescribing professional, compared to doses prescribed for depression.


Q: What is the time frame for feeling the full benefits of Nortrilen when taken for depression?

While the full therapeutic effect on the nervous system can take several weeks, official clinical documents indicate that noticeable improvement in depression symptoms may be observed within the first one to two weeks of being on an appropriate dose.


Q: How long does it typically take before a patient starts noticing effects for nerve pain?

Studies and official information indicate that the full therapeutic effect often takes several weeks to occur. Clinical guidelines describe that a full evaluation of effectiveness often involves a treatment period of six to eight weeks, as described in clinical guidelines.


Q: Why does Nortrilen not work for everyone, even after several weeks of use?

Clinical trials of this class of medication show that a percentage of individuals do not respond to initial treatment, which is known as non-response. Researchers continue to examine treatment-resistant cases to understand individual variability in response.


Q: Why do some people feel worse or experience increased anxiety when first starting Nortrilen?

Regulatory warnings state that changes in mental state, including increased nervousness, restlessness, or panic attacks, can occur when a patient first starts the medication or after a dose change. Official protocol involves the monitoring and reporting of any concerning changes to a healthcare professional.


Q: Is weight gain a commonly reported side effect of taking Nortrilen?

Weight gain is listed in regulatory documentation as a possible side effect. Other changes in metabolism, such as weight loss, are also noted in the official product information.


Q: Is excessive sweating a known side effect of Nortrilen?

Excessive perspiration (sweating) is documented in regulatory safety materials as a possible adverse reaction. It is also noted as a potential withdrawal symptom if the medicine is abruptly stopped.


Q: Can Nortrilen cause unusual emotional changes or bad dreams?

Official documentation lists bad dreams as a possible adverse reaction. Official warnings include that changes in mood or actions are among the potential effects to be aware of, particularly when treatment is initiated.


Q: What are the signs of a severe or serious reaction to Nortrilen that should be reported immediately?

Serious warning signs documented in official labeling include, but are not limited to, fast or irregular heartbeat, seizures, feeling confused, hallucinations, trouble speaking or thinking, or signs of an allergic reaction like swelling or hives. Official warnings emphasize that certain severe outcomes are part of the known risk profile and require prompt attention as directed by a healthcare professional.


Q: What is Serotonin Syndrome, and is it a risk with Nortrilen?

Serotonin Syndrome is a severe condition associated with a build-up of certain chemicals in the body. Official warnings emphasize that it is a serious risk when nortriptyline is used together with Monoamine Oxidase Inhibitors (MAOIs). Symptoms described in regulatory documents include agitation, confusion, tremor, and high body temperature.


Q: Is it normal to feel a lack of energy or motivation when on Nortrilen?

Official side effect profiles frequently list drowsiness, sedation, and lethargy as common occurrences, particularly when treatment is first started. These are often described by patients as feeling a lack of energy or motivation.


Q: Do common side effects, like dry mouth or constipation, usually decrease over time?

Authoritative sources indicate that as the body adjusts to the medicine, some common side effects, such as dry mouth and constipation, may gradually improve.


Q: Are there specific over-the-counter painkillers, like paracetamol or ibuprofen, that interact with Nortrilen?

Authoritative sources state that common over-the-counter painkillers, specifically paracetamol and ibuprofen, do not have known significant interactions with this medicine that would prevent short-term co-administration.


Q: Can driving or operating machinery be affected when first starting this medication?

Official patient safety information describes that because the medicine may cause drowsiness and dizziness, activities requiring mental alertness, such as driving or operating heavy machinery, should be avoided until the patient knows how they are affected.


Q: Is it necessary to avoid excessive sun exposure while taking Nortrilen?

Official documentation lists photosensitization (increased sensitivity to the sun) as a possible skin reaction. Due to this possibility, the use of protective measures like sunscreen and covering up is often described as necessary.


Q: Is Nortrilen considered to be an addictive medication?

Official clinical literature states that the physical withdrawal reaction experienced upon stopping the medication is related to the drug's effect on the body’s chemistry and is distinct from addiction or dependence.


Q: What is discontinuation syndrome, and how does it relate to stopping Nortrilen?

If nortriptyline is stopped after long-term use, withdrawal symptoms (sometimes referred to as Antidepressant Discontinuation Syndrome) may occur. Regulatory guidance describes that when discontinuation is necessary, the medication must be gradually reduced over several weeks under professional supervision.


Q: What are the typical symptoms of withdrawal if Nortrilen is stopped suddenly?

Regulatory documentation notes that if the medication is stopped without the gradual tapering process described in official guidance, possible symptoms may include insomnia, irritability, nausea, headache, and excessive perspiration.

How should Nortrilen be stored and disposed of?

How to Store and Dispose of Nortrilen?

Nortrilen (Nortriptyline Hydrochloride) must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F).


Storage Conditions and Safety

The medication must be dispensed and kept in a tight, light-resistant container to protect it from moisture and light. It is required to keep this medicine out of the sight and reach of children and store it in a secure, locked place to prevent accidental ingestion. The product should not be used after the expiry date printed on the label.


Disposal Instructions

Nortrilen must not be disposed of via wastewater or household waste to protect the environment. Unused or expired medication should be discarded in accordance with local regulations and by consulting a pharmacist on the appropriate pharmaceutical waste collection procedure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nortrilen found in:

A-Z Index: